World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 

US pressures Australia for stronger TPP biologics monopolies

MEDIA RELEASE September 9, 2016

US pressures Australia for even stronger TPP monopolies for biologic drugs

“We are alarmed by reports that US Senate Finance Committee Orrin Hatch says the US administration has “made progress” in talks with Australia and other TPP countries to find a way to increase data protection for costly lifesaving biologic drugs from eight years in the current TPP text to twelve years,”. Dr Patricia Ranald, Convener of the Australian Fair Trade and Investment Network said today.

According to the Bloomberg report copied below. Senator Hatch said “They're going to have to find a way of having the countries agree to change that formality in the TPP to 12 years…If Australia wants to be part of it, they have to meet our terms,” Senator Hatch added that he and the Australian trade minister discussed how they might solve this problem.

Doctor Ranald said that global pharmaceutical companies already have 20 years of monopoly patents on medicines before cheaper versions become available. Biologic medicines under patent, which treat cancer and other serious disease, cost thousands of dollars per treatment. They are only accessible to patients because they are subsidised by the Pharmaceutical Benefits Scheme. Data protection is a separate monopoly which further delays the availability of cheaper forms of those medicines. The current Australian law is five years for data protection, but the TPP text requires administrative measures which would deliver a “market outcome” equivalent to an extra three years of monopoly, a total of eight years. Studies show that each year of delay in cheaper versions of these medicines would cost the PBS hundreds of millions of dollars.

“The extra three years of monopoly in the current TPP text is already unacceptable. It is outrageous that the US is demanding an even greater increase from 8 to 12 years. We call on the Australian and other governments to reject this proposal,” said Doctor Ranald.

“This demand highlights the flaws in the TPP, which is not about free trade, but is about the extension of monopolies and corporate rights. The TPP would also enable pharmaceutical and other global companies to bypass national courts and sue the Australian government in unfair international tribunals over domestic laws. US pharmaceutical company Eli Lilley is currently suing the Canadian government over a court decision which refused a patent for a medicine.

The Australian government has refused to conduct independent assessments of the economic, health and other impacts of the TPP. Sixty community organisations representing over two million Australians last week called for a Senate inquiry into the TPP, to enable a proper assessment of the TPP before Parliament votes on the implementing legislation.” said Dr Ranald.


© Scoop Media

 
 
 
World Headlines

 


Covid-19: Vaccines Donated Next Year, ‘Too Late For Those Who Are Dying Today’

Millions more COVID vaccines need to be donated now to save lives and help the UN health agency reach the key global target of having 70 per cent of all national populations vaccinated, by the middle of 2022... More>>


UN News: Landmark G7 Agreement Pledges 870 Million COVID-19 Vaccine Doses, Half By End-2021

A senior UN official welcomed on Sunday, the Group of Seven (G7) leading industrialized nations’ commitment to immediately share at least 870 million doses of COVID-19 vaccines, supporting global access and helping to end the acute phase of the pandemic... More>>



OECD: G20 GDP Returns To Pre-pandemic Level In The First Quarter Of 2021, But With Large Differences Across Countries

Gross domestic product (GDP) of the G20 area returned to pre-pandemic level in the first quarter of 2021, growing by 0.8% compared with the fourth quarter of 2020. However, this figure conceals large differences across countries... More>>

Focus On: UN SDGs


COP26: Progress Made As May-June UN Climate Change Session Closes

The May-June Climate Change Session, the first to have been held virtually to prepare for the UN Climate Change Conference (COP26) to be held at the end of the year in Glasgow, Scotland, closed today... More>>

UNFCCC: Halving Emissions By 2030 Is New Normal - Race To Zero Anniversary
Over 4,500 non-state actors from across the global economy have committed to halving emissions by 2030, joining the UN-backed Race to Zero campaign... More>>


UN: Tackling Biodiversity & Climate Crises Together And Their Combined Social Impacts

Unprecedented changes in climate and biodiversity, driven by human activities, have combined and increasingly threaten nature, human lives, livelihoods and well-being around the world... More>>